Business News

Verastem – VSTM – Acquires Clinical-Stage FAK Inhibitor from Pfizer

/

Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by […]